A company with the name and ticker symbol of ISIS seems unfortunate. But biotech Isis Pharma is developing an ALS drug any may benefit from the ice bucket challenge that's a social media craze.

  • untitled
CNNMoney assistant managing editor Paul LaMonica highlights the latest news from Wall Street and what's moving the markets in his daily investing commentary.
@LaMonicaBuzz